These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 9283087)
21. The GAF domain of the cGMP-binding, cGMP-specific phosphodiesterase (PDE5) is a sensor and a sink for cGMP. Biswas KH; Sopory S; Visweswariah SS Biochemistry; 2008 Mar; 47(11):3534-43. PubMed ID: 18293931 [TBL] [Abstract][Full Text] [Related]
22. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries. Santos-Silva AJ; Cairrão E; Morgado M; Alvarez E; Verde I Eur J Pharmacol; 2008 Mar; 582(1-3):102-9. PubMed ID: 18234184 [TBL] [Abstract][Full Text] [Related]
23. Cross-regulation of intracellular cGMP and cAMP in cultured human corpus cavernosum smooth muscle cells. Kim NN; Huang Y; Moreland RB; Kwak SS; Goldstein I; Traish A Mol Cell Biol Res Commun; 2000 Jul; 4(1):10-4. PubMed ID: 11152621 [TBL] [Abstract][Full Text] [Related]
24. Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation. Zhu CB; Hewlett WA; Feoktistov I; Biaggioni I; Blakely RD Mol Pharmacol; 2004 Jun; 65(6):1462-74. PubMed ID: 15155839 [TBL] [Abstract][Full Text] [Related]
25. Expression and regulation of the cGMP-binding, cGMP-specific phosphodiesterase (PDE5) in human colonic epithelial cells: role in the induction of cellular refractoriness to the heat-stable enterotoxin peptide. Bakre MM; Sopory S; Visweswariah SS J Cell Biochem; 2000 Feb; 77(1):159-67. PubMed ID: 10679826 [TBL] [Abstract][Full Text] [Related]
26. Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells. Aizawa T; Wei H; Miano JM; Abe J; Berk BC; Yan C Circ Res; 2003 Sep; 93(5):406-13. PubMed ID: 12919948 [TBL] [Abstract][Full Text] [Related]
27. Characterization and phosphorylation of PDE10A2, a novel alternative splice variant of human phosphodiesterase that hydrolyzes cAMP and cGMP. Kotera J; Fujishige K; Yuasa K; Omori K Biochem Biophys Res Commun; 1999 Aug; 261(3):551-7. PubMed ID: 10441464 [TBL] [Abstract][Full Text] [Related]
28. cGMP (guanosine 3',5'-cyclic monophosphate) transport across human erythrocyte membranes. Wu CP; Woodcock H; Hladky SB; Barrand MA Biochem Pharmacol; 2005 Apr; 69(8):1257-62. PubMed ID: 15794947 [TBL] [Abstract][Full Text] [Related]
29. Reconstitution of ATP-dependent cGMP transport into proteoliposomes by membrane proteins from human erythrocytes. Boadu E; Sager G Scand J Clin Lab Invest; 2004; 64(1):41-8. PubMed ID: 15025427 [TBL] [Abstract][Full Text] [Related]
30. Studies of two different intrachain cGMP-binding sites of cGMP-dependent protein kinase. Corbin JD; Døskeland SO J Biol Chem; 1983 Sep; 258(18):11391-7. PubMed ID: 6309846 [TBL] [Abstract][Full Text] [Related]
31. 8-(2-Carboxymethylthio)-cGMP, a site-1-selective compound for cGMP-dependent protein kinase. Landgraf W; Rack M; Heil WG; Hofmann F Eur J Biochem; 1988 Mar; 172(2):439-44. PubMed ID: 2832164 [TBL] [Abstract][Full Text] [Related]
32. Autoradiographic characterization of [3H]cGMP binding sites in the rat brain. Bonkale WL; Cowburn RF; Winblad B; Fastbom J Brain Res; 1997 Jul; 763(1):1-13. PubMed ID: 9272822 [TBL] [Abstract][Full Text] [Related]
33. Interaction of bilirubin with human erythrocyte membranes. Sato H; Kashiwamata S Biochem J; 1983 Feb; 210(2):489-96. PubMed ID: 6860307 [TBL] [Abstract][Full Text] [Related]
34. Effect of probenecid, verapamil and progesterone on the concentration-dependent and temperature-sensitive human erythrocyte uptake and export of guanosine 3',5' cyclic monophosphate (cGMP). Flo K; Hansen M; Orbo A; Kjorstad KE; Maltau JM; Sager G Scand J Clin Lab Invest; 1995 Dec; 55(8):715-21. PubMed ID: 8903841 [TBL] [Abstract][Full Text] [Related]
35. Pharmacological characterization of the ATP-dependent low K(m) guanosine 3',5'-cyclic monophosphate (cGMP) transporter in human erythrocytes. Sundkvist E; Jaeger R; Sager G Biochem Pharmacol; 2002 Mar; 63(5):945-9. PubMed ID: 11911846 [TBL] [Abstract][Full Text] [Related]
36. Studies on the interactions between the cyclic nucleotide-binding sites of cGMP-dependent protein kinase. Døskeland SO; Vintermyr OK; Corbin JD; Ogreid D J Biol Chem; 1987 Mar; 262(8):3534-40. PubMed ID: 3029117 [TBL] [Abstract][Full Text] [Related]
37. Preparation, production and functional characterization of anti cAMP and cGMP antibodies. Defagot C; Zubin P Biol Res; 1994; 27(3-4):193-7. PubMed ID: 8728830 [TBL] [Abstract][Full Text] [Related]
38. The role of OAT2 (SLC22A7) in the cyclic nucleotide biokinetics of human erythrocytes. Sager G; Smaglyukova N; Fuskevaag OM J Cell Physiol; 2018 Aug; 233(8):5972-5980. PubMed ID: 29244191 [TBL] [Abstract][Full Text] [Related]
39. Effects of DNA and synthetic oligodeoxyribonucleotides on the binding properties of a cGMP-binding protein from Dictyostelium discoideum. Parissenti AM; Coukell MB Biochim Biophys Acta; 1990 Sep; 1040(2):294-300. PubMed ID: 2169308 [TBL] [Abstract][Full Text] [Related]
40. Expression of adenosine triphosphate-binding cassette (ABC) drug transporters in peripheral blood cells: relevance for physiology and pharmacotherapy. Köck K; Grube M; Jedlitschky G; Oevermann L; Siegmund W; Ritter CA; Kroemer HK Clin Pharmacokinet; 2007; 46(6):449-70. PubMed ID: 17518506 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]